ProfileGDS4718 / 208324_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 12% 17% 10% 21% 18% 14% 18% 20% 12% 21% 13% 16% 14% 14% 12% 14% 16% 18% 16% 12% 20% 17% 17% 14% 13% 18% 16% 20% 17% 13% 25% 13% 18% 14% 24% 16% 25% 22% 14% 12% 11% 29% 17% 16% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8816612
GSM549102patient 115, normal, homogenized [OPG study]4.0449717
GSM549104patient 119, normal, homogenized [OPG study]3.7515210
GSM549108patient 138, normal, homogenized [OPG study]4.2318221
GSM549119patient 077, normal, homogenized [OPG study]4.0663218
GSM549133patient 032, cancer, homogenized [OPG study]3.8894414
GSM549139patient 042, cancer, homogenized [OPG study]4.0562618
GSM549099patient 107, normal, homogenized [OPG study]4.181120
GSM549109patient 139, normal, homogenized [OPG study]3.8847512
GSM549110patient 046, normal, homogenized [OPG study]4.1950421
GSM549114patient 063, normal, homogenized [OPG study]3.8581413
GSM549122patient 082, normal, homogenized [OPG study]4.0124916
GSM549134patient 033, cancer, homogenized [OPG study]3.9189214
GSM549136patient 036, cancer, homogenized [OPG study]3.8749914
GSM549140patient 044, cancer, homogenized [OPG study]3.8213912
GSM549111patient 047, normal, homogenized [OPG study]3.9158214
GSM549113patient 057, normal, homogenized [OPG study]3.9376316
GSM549132patient 031, cancer, homogenized [OPG study]4.0635718
GSM549137patient 038, cancer, homogenized [OPG study]3.9861916
GSM549142patient 047, cancer, homogenized [OPG study]3.9211812
GSM549100patient 110, normal, homogenized [OPG study]4.1670120
GSM549107patient 135, normal, homogenized [OPG study]4.0084717
GSM549115patient 068, normal, homogenized [OPG study]3.9815117
GSM549116patient 072, normal, homogenized [OPG study]3.9243214
GSM549120patient 078, normal, homogenized [OPG study]3.9022613
GSM549131patient 030, cancer, homogenized [OPG study]4.0101318
GSM549118patient 074, normal, homogenized [OPG study]4.0041216
GSM549129patient 027, cancer, homogenized [OPG study]4.1681620
GSM549123patient 088, normal, homogenized [OPG study]4.031417
GSM549124patient 006, cancer, homogenized [OPG study]3.9128813
GSM549126patient 015, cancer, homogenized [OPG study]4.3119425
GSM549128patient 025, cancer, homogenized [OPG study]3.8511613
GSM549103patient 117, normal, homogenized [OPG study]4.0934618
GSM549117patient 073, normal, homogenized [OPG study]3.9274114
GSM549138patient 041, cancer, homogenized [OPG study]4.2669224
GSM549141patient 045, cancer, homogenized [OPG study]3.9388716
GSM549130patient 028, cancer, homogenized [OPG study]4.3563725
GSM549101patient 111, normal, homogenized [OPG study]4.2418722
GSM549105patient 128, normal, homogenized [OPG study]3.9398314
GSM549106patient 134, normal, homogenized [OPG study]3.7942512
GSM549112patient 048, normal, homogenized [OPG study]3.8090311
GSM549125patient 011, cancer, homogenized [OPG study]4.5076229
GSM549127patient 024, cancer, homogenized [OPG study]3.9966417
GSM549135patient 035, cancer, homogenized [OPG study]3.9503316